Press Release NeonMind CEO Robert Tessarolo to Speak at the Psychedelic, Therapeutics, & Drug Development Conference
Press Release NeonMind CEO Provides Update on the Progress of its Psilocybin Drug Development Research Plan and Team
Press Release NeonMind Engages Certara to Advance its Synthetic Psilocybin Drug Candidates for Obesity
Press Release NeonMind Engages Pharma Executive Philippe Martin to Advance its Psilocybin Drug Candidates for Obesity
Press Release NeonMind Purchases GMP Grade Synthetic Psilocybin from Psygen Labs for Phase 2 Human Clinical Trial
Press Release NeonMind Submits Applications to Health Canada for Product Formulas to Support Cognitive and Immune Function and to Fight Stress
